ARCHIVES

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

FDA Approves Two PSA Tests By roche; Onconase Gets EU Orphan Designation.

March 2, 2001

In Brief: Former HHS Official Could Replace Heckler, Reagan Signs Federal Cigarette Tax Extension

October 11, 1985

Childhood Cancer Survivors Do Not Have an Increased Risk Of Passing On Birth Defects

December 30, 2011

Dingell Asks FDA To Explain Failure To Curtail ESA Ads.

June 15, 2007

In Brief: Big Ten Cancer Research Consortium Names Executive Officer

May 30, 2014

DeVita Denies NCI Broke Faith With Communities On CHOP Awards, Says Total Of 30 “Not Absolute”

August 15, 1980